Abstract
Can machine learning models identify which chemist made a molecule from structure alone? If so, models trained on literature data may exploit chemist intent rather than learning causal structure-activity relationships. We test this by linking CHEMBL assays to publication authors and training a 1,815-class classifier to predict authors from molecular fingerprints, achieving 60% top-5 accuracy under scaffold-based splitting. We then train an activity model that receives only a protein identifier and an author-probability vector derived from structure, with no direct access to molecular descriptors. This author-only model achieves predictive power comparable to a simple baseline that has access to structure. This reveals a "Clever Hans" failure mode: models can predict bioactivity largely by inferring chemist goals and favorite targets without requiring a lab-independent understanding of chemistry. We analyze the sources of this leakage, propose author-disjoint splits, and recommend dataset practices to decouple chemist intent from biological outcomes.